期刊文献+

脊髓背角小胶质细胞组织蛋白酶S在大鼠骨癌痛维持中的作用

Role of cathepsin S in spinal microglia in maintenance of bone cancer pain in rats
原文传递
导出
摘要 目的 探讨脊髓背角小胶质细胞组织蛋白酶S(CatS)在大鼠骨癌痛维持中的作用.方法 雌性未交配SD大鼠50只,4~6周龄,体重150~ 180 g,采用随机数字表法,将其分为5组(n=10):假手术组(S组)、骨癌痛组(BCP组)、假手术+CatS抑制剂吗啉亮氨酸高苯丙氨酸乙烯基苯基砜(LHVS)组(S+L组)、骨癌痛+二甲基亚砜组(BCP+D组)和骨癌痛+LHVS组(BCP+L组).左侧胫骨骨髓腔内接种浓度为2×107/ml Walker256细胞5μl制备大鼠骨癌痛模型.分别于造模后10、11、12d时S+L组和BCP+L组鞘内注射LHVS 50 nmol/10l,1次/d,BCP+D组给予等容量二甲基亚砜.分别于造模前1d(基础状态)及造模后3、6、9、10、11、12 d(T0-6)测定机械缩爪反应阈(MWT),分别于鞘内给药前、鞘内给药后0.5、1.0、3.0、6.0、9.0、12.0、24.0 h时测定(MWT).处死大鼠,取L4-6脊髓组织,采用免疫组化法测定OX-42表达.结果 与S组比较,BCP组、BCP+D组和BCP+L组T2-6时MWT降低,脊髓背角OX-42表达上调(P<0.01),S+L组MWT和脊髓背角OX-42表达差异无统计学意义(P>0.05);与BCP组比较,BCP+L组T4-6时MWT升高,脊髓背角OX-42表达下调(P<0.01),BCP+D组MWT和脊髓背角0X-42表达差异无统计学意义(P>0.05).S+L组和BCP+D组鞘内给药后3.0、6.0、9.0h时MWT低于BCP+D组(P<0.01).结论 脊髓背角小胶质细胞CatS激活参与了大鼠骨癌痛的维持. Objective To investigate the role of cathepsin S (CatS) in spinal microglia in the maintenance of bone cancer pain (BCP) in rats.Methods Fifty unmated female Sprague-Dawley rats,aged 4-6 months,weighing 150-180 g,were randomly divided into 5 groups with 10 rats in each group:sham operation group (group S) ; group BCP; sham operation + CatS inhibitor morpholinurea-leucine-homophenylalanine-vinyl phenyl sulfone (LHVS) group (group S + L); BCP + dimethyl sulfoxide (DMSO) group (group BCP + D); BCP + LHVS group (group BCP + L).BCP was induced by inoculating 2 × 107/ml Walker256 mammary gland carcinoma cells 5 μl into the medullary cavity of the left tibia,while in S and S + L groups,Hank' s solution 5μl was injected into left tibia instead of Walker256 cells.At 10,11 and 12 days after inoculation,the rats in S + L and BCP + L groups received an intrathecal injection of LHVS 50 nmol/10μl,and the rats in group BCP + D received an intrathecal injection of 5 % DMSO 10 μl.Mechanical paw withdrawal threshold (MWT) was measured at 1 day before inoculation (baseline) and 3,6,9,10,11 and 12 days after inoculation (T0-6).MWT was measured before intrathecal administration and at 0.5,1.0,3.0,6.0,9.0,12.0 and 24.0 h after intrathecal administration.The rats were sacrificed and the L4-6 segments of the spinal cord were removed for determination of the expression of OX-42 in the spinal dorsal horn by immunohistochemistry.Results Compared with group S,MWT was significantly decreased at T2-6 and the expression of OX-42 in spinal dorsal horn was up-regulated in BCP,BCP + D and BCP + L groups (P < 0.01),and no significant changes in MWT and expression of OX-42 in spinal dorsal horn were found in S + L group (P > 0.05).Compared with group BCP,MWT was significantly increased at T4-6 and the expression of OX-42 in spinal dorsal horn was down-regulated in group BCP+ L (P < 0.01),and no significant change in MWT and the expression of OX-42 in spinal dorsal horn was found in group BCP + D (P > 0.05).MWT was significantly decreased at 3.0,6.0 and 9.0 h after intrathecal administration in S + L and BCP + D groups as compared with BCP + D group (P < 0.01).Conclusion Activation of CatS in spinal microglia is involved in the maintenance of BCP in rats.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2013年第7期860-863,共4页 Chinese Journal of Anesthesiology
基金 国家自然科学基金(81171057,81000479) 江苏省自然科学基金(SBK201121879) 高校博士点基金(SZ12200411) 江苏省临床医学科技专项(重点病种的规范化诊疗研究)(SBL201220104)
关键词 半胱氨酸内肽酶类 小神经胶质细胞 脊髓 疼痛 骨肿瘤 Cysteine endopeptidases Microglia Spinal cord Pain Bone neoplasms
  • 相关文献

参考文献12

  • 1Thurlimann B, de Stoutz ND. Causes and treatment of bone pain of malignant origin. Drugs, 1996, 51(3): 383-398.
  • 2Meuser T, Pietruck C, Radbruch L, et al. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain, 2001, 93 (3) : 247-257.
  • 3Zhang RX, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inocu- lation of the tibia. Pain, 2005, 118(1-2) : 125-136.
  • 4Clark AK, Yip PK, Malcangio M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci, 2009, 29 (21) : 6945-6954.
  • 5Clark AK, Malcangio M. Microglial signalling mechanisms: catbep- sin S and Fractalkine. Exp Neurol, 2012,234(2) : 283-292.
  • 6Clark AK, Wodar S, Guida F, et al. Cathepsin S release from pri-mary cultured mieroglia is regulated by the P2Y7 receptor. Glia, 2010, 58(14) : 1710-1726.
  • 7Clark AK, Yip PK, Grist J, et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Aead Sci USA, 2007, 104(25): 10655-10660.
  • 8Clark AK, Grist J, A1-Kashi A, et al. Spinal cathepsin S and fracta- lkine contribute to chronic pain in the collagen-induced arthritis mod- el. Arthritis Rheuma, 2012,64(6) : 2038-2047.
  • 9Barclay J, Clark AK, Ganju P, et al. Role of the cysteine protease cathepsin S in neuropathic hyperalgesia. Pain, 2007, 130(3) : 225- 234.
  • 10姚明,杨建平,王丽娜,成浩,张艳兵,许期年,吴翼伟.腹水传代与体外培养Walker 256癌细胞系建立大鼠骨癌痛模型的可行性[J].中华医学杂志,2008,88(13):880-884. 被引量:61

二级参考文献13

  • 1Rubens RD. Bone metastases-the clinical problem. Eur J Cancer, 1998, 34: 211-213.
  • 2Medhursta SJ, Walker K, Bowes M, et al. A rat model of bone cancer pain, Pain, 2002, 96:129-140.
  • 3Zhang RX, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain, 2005, 118 : 125-136.
  • 4Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci ,1999, 19: 10886-10897.
  • 5Halvorson KG, Kubota K, Sevcik MA, et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res, 2005, 65 : 9426-9435.
  • 6Walker K. Fox AJ, Urban LA. Animal models for pain research. Mol Med Today, 1999, 5: 319-321.
  • 7Corbello Pereira SR, Darronqui E, Constantin J, et al. The urea cycle and related pathways in the liver of Walker-256 tumorbearing rats. Biochim Biophys Acta, 2004, 1688: 187-196.
  • 8Yao YM, Liu QG, Yang W, et al. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis. Hepatobiliary Pancreat Dis Int, 2003, 2: 242-246.
  • 9Chew EC, Wallace AC. Demonstration of fibrin in early stages of experimental metastases. Cancer Res, 1976, 36:1904-1909.
  • 10Menendez L, Lastra A, Fresno MF et al. Initial thermal heat hypoalgesia and delayed hyperalgesia in a routine model of bone cancer pain. Brain Res, 2003, 969: 102-109.

共引文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部